WCMNY
BIOTU

Westchester Capital Management (New York)’s Biotech Acquisition Company Unit BIOTU Stock Holding History

Westchester Capital Management (New York)’s Portfolio BIOTU Stock Details BIOTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-50,000
Closed -$494K – 450
2022
Q1 		$494K Hold
50,000
– – 0.01% 331
2021
Q4 		$501K Hold
50,000
– – 0.01% 298
2021
Q3 		$502K Hold
50,000
– – 0.01% 262
2021
Q2 		$504K Hold
50,000
– – 0.01% 243
2021
Q1 		$494K Buy
+50,000
New +$514K 0.01% 260

Other funds holding BIOTU

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Westchester Capital Management (New York)'s BIOTU Position: Q2 2022 in Review

Westchester Capital Management (New York) sold out of Biotech Acquisition Company Unit (BIOTU) in Q2 2022, closing a stake of 50,000 shares — an estimated $494K sold.

Westchester Capital Management (New York) first reported a position in BIOTU in Q1 2021 and held it in 5 quarters. The position peaked at $504K in Q2 2021. 5 funds tracked by Wall St. Rank hold BIOTU as of Q2 2022.

  • Westchester Capital Management (New York) reported no remaining Biotech Acquisition Company Unit position as of Q2 2022 after selling out during the quarter.
  • Westchester Capital Management (New York) sold 50,000 Biotech Acquisition Company Unit shares in Q2 2022, an estimated $494K.
  • Westchester Capital Management (New York) first reported a position in Biotech Acquisition Company Unit in Q1 2021 and held it in 5 quarters.
  • Westchester Capital Management (New York)'s Biotech Acquisition Company Unit position peaked at $504K in Q2 2021.
  • 5 funds tracked by Wall St. Rank held Biotech Acquisition Company Unit as of Q2 2022.

Based on Westchester Capital Management (New York)'s 13F filing for Q2 2022, filed 15 Aug 2022.